Keros Therapeutics (KROS) EBITDA (2019 - 2026)
Keros Therapeutics (KROS) recorded EBITDA of -$28.87 million in Q4 2025, compared with -$52.92 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) EBITDA (2019 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics reported EBITDA of $69.08 million.
- Across earlier years, EBITDA came in at -$209.6 million in FY2024, -$169.13 million in FY2023, -$114.12 million in FY2022 and -$56 million in FY2021.
- Quarterly EBITDA has ranged from -$58.34 million in Q3 2024 to $152.38 million in Q1 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$14.99 million (Q3 2025), -$39.45 million (Q2 2025) and $152.38 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 13.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.20 Mn |
| Jun 30, 2026 | -30.54 Mn |
| Mar 31, 2026 | -25.47 Mn |
| Dec 31, 2025 | -28.87 Mn |
| Sep 30, 2025 | -14.99 Mn |
| Jun 30, 2025 | -39.45 Mn |
| Mar 31, 2025 | 152.38 Mn |
| Dec 31, 2024 | -52.92 Mn |
| Sep 30, 2024 | -58.34 Mn |
| Jun 30, 2024 | -50.13 Mn |
| Mar 31, 2024 | -48.21 Mn |
| Dec 31, 2023 | -46.21 Mn |
| Sep 30, 2023 | -43.07 Mn |
| Jun 30, 2023 | -41.15 Mn |
| Mar 31, 2023 | -38.70 Mn |
| Dec 31, 2022 | -31.83 Mn |
| Sep 30, 2022 | -27.85 Mn |
| Jun 30, 2022 | -30.42 Mn |
| Mar 31, 2022 | -24.01 Mn |
| Dec 31, 2021 | -4.76 Mn |
API Access
Keros Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();